Insulet
PODD
133.17
-4.06
-2.96%
Insulet
US · PODD
#1561 by market cap
Listed 1970
133.17
-4.06
-2.96%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Recent news
-
Rating change
Citigroup Maintains Neutral on Insulet, Raises Price Target to $170Benzinga · 2026/11/6
-
Company notice
Insulet | SCHEDULE 13G/A: OthersSEC · 2026/10/28
-
Company notice
Insulet | 8-K: Insulet Reports Third Quarter 2026 ResultsSEC · 2026/11/4
-
A Quick Look at Today's Ratings for Insulet(PODD.US), With a Forecast Between $165 to $200Market Newswire · 2026/11/6
-
Truist Financial Maintains Insulet(PODD.US) With Hold Rating, Raises Target Price to $160Market Newswire · 2026/11/9
-
Company notice
Insulet | 4: Statement of changes in beneficial ownership of securities-Officer Pease FlaviaSEC · 2026/10/6
-
Rating change
Barclays Maintains Equal-Weight on Insulet, Raises Price Target to $165Benzinga · 2026/11/7
-
Company notice
Insulet | 10-Q: Q3 2026 Earnings ReportSEC · 2026/11/5
-
Truist Securities Adjusts Price Target on Insulet to $160 From $153, Keeps Hold RatingMT Newswires · 2026/11/9
-
Rating change
Insulet Is Maintained at Outperform by BernsteinDow Jones · 2026/11/6
-
Company notice
Insulet | SCHEDULE 13G: OthersSEC · 2026/11/13
-
Rating change
Insulet Price Target Raised to $167.00/Share From $143.00 by Leerink PartnersDow Jones · 2026/11/6
-
Rating change
UBS Maintains Neutral on Insulet, Raises Price Target to $171Benzinga · 2026/11/6
-
Rating change
Insulet Price Target Raised to $170.00/Share From $152.00 by JP MorganDow Jones · 2026/11/6
-
Barclays Maintains Insulet(PODD.US) With Hold Rating, Raises Target Price to $165Market Newswire · 2026/11/7
-
Rating change
Insulet Is Maintained at Neutral by CitigroupDow Jones · 2026/11/6
-
Wells Fargo Downgrades Insulet(PODD.US) to Hold Rating, Cuts Target Price to $172Market Newswire · 2026/11/6
-
Rating change
Insulet Price Target Raised to $170.00/Share From $150.00 by CitigroupDow Jones · 2026/11/6
-
Rating change
JP Morgan Maintains Neutral on Insulet, Raises Price Target to $170Benzinga · 2026/11/6
-
Rating change
Insulet Price Target Raised to $165.00/Share From $150.00 by BarclaysDow Jones · 2026/11/7
-
Rating change
Jefferies Maintains Buy on Insulet, Lowers Price Target to $190Benzinga · 2026/10/13
-
Rating change
Leerink Partners Maintains Insulet(PODD.US) With Hold Rating, Cuts Target Price to $143Market Newswire · 2026/10/12
-
Rating change
Insulet Is Maintained at Buy by JefferiesDow Jones · 2026/10/13
-
Rating change
Barclays Initiates Insulet(PODD.US) With Hold Rating, Announces Target Price $150Market Newswire · 2026/10/8
-
Barclays Upgrades Insulet(PODD.US) to Hold Rating, Cuts Target Price to $150Market Newswire · 2026/10/7
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:01:08 · For reference only, not investment advice and not tailored to your situation.
Insulet discussion 0 comments